Profile for Cerus Corporation (CERS)

$ 5.03   -0.13 (-2.52%) Volume: 2.67m 4:00 PM EST Feb 24, 2020
After Hours:  $ 5.05   0.02 (+0.40%) Volume: 249.15k 7:36 PM EST Feb 24, 2020
Business Description:
Cerus Corp is a biomedical products company. It is engaged in developing and commercializing the INTERCEPT Blood System to enhance blood safety.
Address: 2550 Stanwell Drive, Concord, CA, USA, 94520
Telephone: +1 925 288-6000 Website: http://www.cerus.com
Facsimile: N/A Email: [email protected]
Details
CEO: William M. Greenman
Employees: 240 Market Cap: 799.55m
Issue Type: CS
Auditor: Ernst & Young LLP
Last Audit: Unqualified Opinion
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 1020214
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Biological Product (except Diagnostic) Manufacturing (325414)
SIC: Pharmaceutical Preparations (2834)